56 related articles for article (PubMed ID: 10943860)
1. Expression of concern: GZMB gene silencing confers protection against synovial tissue hyperplasia and articular cartilage tissue injury in rheumatoid arthritis through the MAPK signaling pathway [Biomedicine & Pharmacotherapy 103 (2018) 346-354].
Biomed Pharmacother; 2022 Nov; 155():113814. PubMed ID: 36271519
[No Abstract] [Full Text] [Related]
2. The forgotten key players in rheumatoid arthritis: IL-8 and IL-17 - Unmet needs and therapeutic perspectives.
Gremese E; Tolusso B; Bruno D; Perniola S; Ferraccioli G; Alivernini S
Front Med (Lausanne); 2023; 10():956127. PubMed ID: 37035302
[TBL] [Abstract][Full Text] [Related]
3. Molecular imaging of the urokinase plasminogen activator receptor: opportunities beyond cancer.
Baart VM; Houvast RD; de Geus-Oei LF; Quax PHA; Kuppen PJK; Vahrmeijer AL; Sier CFM
EJNMMI Res; 2020 Jul; 10(1):87. PubMed ID: 32725278
[TBL] [Abstract][Full Text] [Related]
4. A suppressive effect of prostaglandin E
Masuko K; Murata M; Suematsu N; Okamoto K; Yudoh K; Shimizu H; Beppu M; Nakamura H; Kato T
Open Access Rheumatol; 2009; 1():9-15. PubMed ID: 27789978
[TBL] [Abstract][Full Text] [Related]
5. Urokinase-type plasminogen activator and arthritis progression: contrasting roles in systemic and monoarticular arthritis models.
De Nardo CM; Lenzo JC; Pobjoy J; Hamilton JA; Cook AD
Arthritis Res Ther; 2010; 12(5):R199. PubMed ID: 20973954
[TBL] [Abstract][Full Text] [Related]
6. Synovial fibroblasts spread rheumatoid arthritis to unaffected joints.
Lefèvre S; Knedla A; Tennie C; Kampmann A; Wunrau C; Dinser R; Korb A; Schnäker EM; Tarner IH; Robbins PD; Evans CH; Stürz H; Steinmeyer J; Gay S; Schölmerich J; Pap T; Müller-Ladner U; Neumann E
Nat Med; 2009 Dec; 15(12):1414-20. PubMed ID: 19898488
[TBL] [Abstract][Full Text] [Related]
7. Proteinases in the joint: clinical relevance of proteinases in joint destruction.
Rengel Y; Ospelt C; Gay S
Arthritis Res Ther; 2007; 9(5):221. PubMed ID: 18001502
[TBL] [Abstract][Full Text] [Related]
8. Comparison of pancreas juice proteins from cancer versus pancreatitis using quantitative proteomic analysis.
Chen R; Pan S; Cooke K; Moyes KW; Bronner MP; Goodlett DR; Aebersold R; Brentnall TA
Pancreas; 2007 Jan; 34(1):70-9. PubMed ID: 17198186
[TBL] [Abstract][Full Text] [Related]
9. The plasminogen activator/plasmin system is essential for development of the joint inflammatory phase of collagen type II-induced arthritis.
Li J; Ny A; Leonardsson G; Nandakumar KS; Holmdahl R; Ny T
Am J Pathol; 2005 Mar; 166(3):783-92. PubMed ID: 15743790
[TBL] [Abstract][Full Text] [Related]
10. Plasminogen activation/plasmin in rheumatoid arthritis: matrix degradation and more.
Judex MO; Mueller BM
Am J Pathol; 2005 Mar; 166(3):645-7. PubMed ID: 15743776
[TBL] [Abstract][Full Text] [Related]
11. Discrepancy between mRNA and protein expression of tumour suppressor maspin in synovial tissue may contribute to synovial hyperplasia in rheumatoid arthritis.
Schedel J; Distler O; Woenckhaus M; Gay RE; Simmen B; Michel BA; Müller-Ladner U; Gay S
Ann Rheum Dis; 2004 Oct; 63(10):1205-11. PubMed ID: 15361372
[TBL] [Abstract][Full Text] [Related]
12. Gene targeting: roadmap to future therapies.
Huber LC; Pap T; Müller-Ladner U; Gay RE; Gay S
Curr Rheumatol Rep; 2004 Oct; 6(5):323-5. PubMed ID: 15355741
[No Abstract] [Full Text] [Related]
13. Plasminogen activator inhibitor-1 as a link between pathological fibrinolysis and arthritis of Behçet's disease.
Oztürk MA; Ertenli I; Kiraz S; C Haznedaroğlu I; Celik I; Kirazli S; Calgüneri M
Rheumatol Int; 2004 Mar; 24(2):98-102. PubMed ID: 12750940
[TBL] [Abstract][Full Text] [Related]
14. Urokinase, a constitutive component of the inflamed synovial fluid, induces arthritis.
Jin T; Tarkowski A; Carmeliet P; Bokarewa M
Arthritis Res Ther; 2003; 5(1):R9-R17. PubMed ID: 12716448
[TBL] [Abstract][Full Text] [Related]
15. Inflammation, immune reactivity, and angiogenesis in a severe combined immunodeficiency model of rheumatoid arthritis.
Davis LS; Sackler M; Brezinschek RI; Lightfoot E; Bailey JL; Oppenheimer-Marks N; Lipsky PE
Am J Pathol; 2002 Jan; 160(1):357-67. PubMed ID: 11786429
[TBL] [Abstract][Full Text] [Related]
16. Cartilage degradation and invasion by rheumatoid synovial fibroblasts is inhibited by gene transfer of a cell surface-targeted plasmin inhibitor.
van der Laan WH; Pap T; Ronday HK; Grimbergen JM; Huisman LG; TeKoppele JM; Breedveld FC; Gay RE; Gay S; Huizinga TW; Verheijen JH; Quax PH
Arthritis Rheum; 2000 Aug; 43(8):1710-8. PubMed ID: 10943860
[TBL] [Abstract][Full Text] [Related]
17. Cartilage degradation and invasion by rheumatoid synovial fibroblasts is inhibited by gene transfer of TIMP-1 and TIMP-3.
van der Laan WH; Quax PH; Seemayer CA; Huisman LG; Pieterman EJ; Grimbergen JM; Verheijen JH; Breedveld FC; Gay RE; Gay S; Huizinga TW; Pap T
Gene Ther; 2003 Feb; 10(3):234-42. PubMed ID: 12571631
[TBL] [Abstract][Full Text] [Related]
18. Gene transfer of cytokine inhibitors into human synovial fibroblasts in the SCID mouse model.
Müller-Ladner U; Evans CH; Franklin BN; Roberts CR; Gay RE; Robbins PD; Gay S
Arthritis Rheum; 1999 Mar; 42(3):490-7. PubMed ID: 10088772
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
